002493.SZ
002493.SZ
CNE100000W60
RSPC
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)
0.97x
Defensive
Volatility (5Y p.a.)
35.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-61.3%
5-Year Horizon
Sharpe Ratio
-0.29
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +34%
3 Years 34.8% -35.2% 0.03 +3.5%
5 Years 35.5% -61.3% -0.29 -7.3%
10 Years 43.4% -73.7% 0.26 +13.8%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 210%.
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (35.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -73.7% in the extended horizon.
ende